butorphanol

(redirected from Butorphanol tartrate)
Also found in: Medical, Acronyms.
Related to Butorphanol tartrate: Stadol

bu·tor·pha·nol

 (byo͞o-tôr′fə-nŏl)
n.
A synthetic opioid drug, C21H29NO2, given by injection or nasal spray in its tartrate form to treat pain and to supplement anesthesia.

[but(yl) + (m)orph(in)an, structural basis of a group of opioids; see dextromethorphan + -ol.]
References in periodicals archive ?
In vitro characterization of a formulation of butorphanol tartrate in a poloxamer 407 base intended for use as a parenterally administered slow-release analgesic agent.
Sedation and analgesia were performed using butorphanol tartrate (4mg [kg.
05 mg/kg (intramuscular) and butorphanol tartrate at a dose of 0.
NYSE:MYL) announced today that it has acquired an Abbreviated New Drug Application for the sale of Butorphanol Tartrate Nasal Spray, 10 mg/mL.
Pharmacokinetics of butorphanol tartrate in a longacting poloxamer 407 gel formulation administered to Hispaniolan Amazon parrots (Amazona ventrallis).
Food and Drug Administration (FDA) for butorphanol tartrate injection, USP, a generic injectable drug for pain management.
Liposome-encapsulated butorphanol tartrate, a long-acting preparation, showed promise in psittacine birds, (9-10) with analgesic effects lasting 3-5 days after a single subcutaneous injection.
3) Reviewed chemistry, pharmacology, uses, side effects, pharmacokinetics and dosage of Butorphanol tartrate.
It previously received approval for butorphanol tartrate, the generic version of Stadol(R) brand injection marketed by Apothecon, on 28 September 1998.
Butorphanol tartrate (1 mg/kg IM q24h, Torbugesic, Fort Dodge Laboratories, Fort Dodge, IA, USA) was administered for analgesia before handling the bird for daily wound debridement.